Alerts will be sent to your verified email
Verify EmailAMRAPLIN
|
Amrapali Industries
|
Supha Pharmachem
|
Filtra Consultants
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.36 % | 38.8 % | 14.05 % |
|
5yr average Equity Multiplier
|
5.15 | 60.3 | 1.85 |
|
5yr Average Asset Turnover Ratio
|
174.43 | 1.25 | 2.36 |
|
5yr Avg Net Profit Margin
|
0.0 | 0.65 % | 3.2 % |
|
Price to Book
|
2.28 | 0.72 | 3.27 |
|
P/E
|
38.24 | 35.62 | 27.09 |
|
5yr Avg Cash Conversion Cycle
|
0.31 Days | 478.33 Days | 36.46 Days |
|
Inventory Days
|
0.29 Days | 78.27 Days | 55.87 Days |
|
Days Receivable
|
0.0 | 694.98 Days | 34.62 Days |
|
Days Payable
|
0.07 Days | 156.76 Days | 66.81 Days |
|
5yr Average Interest Coverage Ratio
|
1.31 | 9.58 | 65.13 |
|
5yr Avg ROCE
|
17.8 % | 66.83 % | 19.83 % |
|
5yr Avg Operating Profit Margin
|
0.01 % | 0.73 % | 4.39 % |
|
5 yr average Debt to Equity
|
2.09 | 6.84 | 0.02 |
|
5yr CAGR Net Profit
|
17.46 % | 14.55 % | 9.36 % |
|
5yr Average Return on Assets
|
0.74 % | 0.69 % | 7.6 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.43 % | 1.13 % | 72.45 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.02 % | -0.73 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Amrapali Industries
|
Supha Pharmachem
|
Filtra Consultants
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|